Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab-Associated Conjunctivitis in Patients with Atopic Dermatitis

被引:6
作者
Patra, Vijaykumar [1 ,2 ]
Woltsche, Nora [3 ]
Cerpes, Urban [1 ]
Bokanovic, Danijela [1 ]
Repelnig, Maria [1 ]
Joshi, Aaroh [1 ]
Perchthaler, Isabella [1 ]
Fischl, Manuela
Vocanson, Marc [2 ]
Bordag, Natalie [1 ]
Durdevic, Marija [4 ,5 ,6 ]
Woltsche, Johannes [1 ]
Quehenberger, Franz [1 ]
Legat, Franz [1 ]
Wedrich, Andreas [3 ]
Horwath-Winter, Jutta [3 ]
Wolf, Peter [7 ,8 ]
机构
[1] Med Univ Graz, Dept Dermatol, Graz, Austria
[2] Univ Lyon, Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, Inst Natl St & Rech Medicale,U1111,Ctr Int Rech I, Lyon, France
[3] Med Univ Graz, Dept Ophthalmol, Graz, Austria
[4] Med Univ Graz, Ctr Med Res, Computat Bioanalyt, Graz, Austria
[5] Med Univ Graz, Inst Pathol, Graz, Austria
[6] Med Univ Graz, Theodor Escherich Lab Med Microbiome Res, Graz, Austria
[7] BioTechMed Graz, Graz, Austria
[8] Med Univ Graz, Dept Dermatol & Venereol, Res Unit Photodermatol, Auen Bruggerpl 8, A-8036 Graz, Austria
来源
OPHTHALMOLOGY SCIENCE | 2024年 / 4卷 / 01期
关键词
Dupilumab; Atopic dermatitis; Microbiome; Cytokines; Neutrophils; SEASONAL ALLERGIC CONJUNCTIVITIS; PATHOPHYSIOLOGY; ACETOBACTER; DISEASE; PLACEBO; ADULTS; RISK;
D O I
10.1016/j.xops.2023.100340
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To elucidate the pathogenesis of dupilumab (Dupixent (R))-associated ocular surface disease Subjects: Twenty patients with moderate-to-severe atopic dermatitis (AD) who received dupilumab and 10 age- and sex-matched healthy controls were enrolled in the study. Methods: The study cohort underwent a thorough slit-lamp and entire-body dermatologic examination. Conjunctival swabs and smears were collected at baseline, 4 and 16 weeks after treatment initiation, and during the conjunctivitis episode. To analyse the ocular surface microbiome, 16S ribosomal RNA sequencing was performed, smears were hematoxylin and eosin stained, and serum cytokines were measured by using a multiplex immunobead assay. Main Outcome Measures: Composition of ocular surface microbiome and cellular component as well as serum cytokine levels. Results: Six of the 20 patients with AD developed DAOSD after dupilumab initiation; these patients responded after a delay to treatment as quantified by Eczema Area and Severity Index and Investigator's Global Assessment score. Conjunctival smears showed massive neutrophilic infiltration and serum analysis revealed increased systemic levels of neutrophil-priming proinflammatory cytokines, in particular interleukin-1b and tumor necrosis factor a, in patients with DAOSD compared with those without it. The ocular surface microbiome of patients with DAOSD was characterized by a diverse and persistent microbial colonization, particularly by Acetobacter aceti. In contrast, microbial diversity decreased in patients with AD without DAOSD after the initiation of dupilumab treatment, especially the abundance of Staphylococcus aureus. In vitro experiments substantiated the potential role of the microbiome, showing increased growth of A. aceti and decreased growth of S. aureus in presence of dupilumab. Conclusions: Persistent neutrophilic infiltration and a unique microbial landscape on the ocular surface associated with elevated levels of systemic proinflammatory cytokines typify DAOSD. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references. Ophthalmology Science 2024;4:100340 (c) 2023 by the American Academy of Ophthalmology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:16
相关论文
共 49 条
  • [1] High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease
    Achten, Roselie
    Thijs, Judith
    van der Wal, Marlot
    van Luijk, Chantal
    van Luin, Matthijs
    el Amrani, Mohsin
    Knol, Edward
    Delemarre, Eveline
    Jager, Constance den Hartog
    de Graaf, Marlies
    Bakker, Daphne
    de Boer, Joke
    van Wijk, Femke
    de Bruin-Weller, Marjolein
    [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2023, 13 (01)
  • [2] Conjunctivitis in dupilumab clinical trials
    Akinlade, B.
    Guttman-Yassky, E.
    de Bruin-Weller, M.
    Simpson, E. L.
    Blauvelt, A.
    Cork, M. J.
    Prens, E.
    Asbell, P.
    Akpek, E.
    Corren, J.
    Bachert, C.
    Hirano, I.
    Weyne, J.
    Korotzer, A.
    Chen, Z.
    Hultsch, T.
    Zhu, X.
    Davis, J. D.
    Mannent, L.
    Hamilton, J. D.
    Teper, A.
    Staudinger, H.
    Rizova, E.
    Pirozzi, G.
    Graham, N. M. H.
    Shumel, B.
    Ardeleanu, M.
    Wollenberg, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (03) : 459 - 473
  • [3] Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration
    Anderson, DF
    MacLeod, JDA
    Baddeley, SM
    Bacon, AS
    McGill, JI
    Holgate, ST
    Roche, WR
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (09) : 1060 - 1066
  • [4] The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders
    Aragona, Pasquale
    Baudouin, Christophe
    del Castillo, Jose M. Benitez
    Messmer, Elisabeth
    Barabino, Stefano
    Merayo-Lloves, Jesus
    Brignole-Baudouin, Francoise
    Inferrera, Leandro
    Rolando, Maurizio
    Mencucci, Rita
    Rescigno, Maria
    Bonini, Stefano
    Labetoulle, Marc
    [J]. SURVEY OF OPHTHALMOLOGY, 2021, 66 (06) : 907 - 925
  • [5] Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
    Bakker, D. S.
    Ariens, L. F. M.
    van Luijk, C.
    van der Schaft, J.
    Thijs, J. L.
    Schuttelaar, M. L. A.
    van Wijk, F.
    Knol, E. F.
    Balak, D. M. W.
    van Dijk, M. R.
    de Bruin-Weller, M. S.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : 1248 - 1249
  • [6] Dupilumab-Associated Mucin Deficiency (DAMD)
    Barnett, Brad P.
    Afshari, Natalie A.
    [J]. TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2020, 9 (03):
  • [7] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [8] Targeting T2 Inflammation by Dupilumab Impacts on the Microbiomic "Menage a Trois" of Atopic Dermatitis
    Bieber, Thomas
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (01) : 15 - 17
  • [9] Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein
    Gooderham, Melinda
    Cather, Jennifer C.
    Weisman, Jamie
    Pariser, David
    Simpson, Eric L.
    Papp, Kim A.
    Hong, H. Chih-Ho
    Rubel, Diana
    Foley, Peter
    Prens, Errol
    Griffiths, Christopher E. M.
    Etoh, Takafumi
    Pinto, Pedro Herranz
    Pujol, Ramon M.
    Szepietowski, Jacek C.
    Ettler, Karel
    Kemeny, Lajos
    Zhu, Xiaoping
    Akinlade, Bolanle
    Hultsch, Thomas
    Mastey, Vera
    Gadkari, Abhijit
    Eckert, Laurent
    Amin, Nikhil
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Stahl, Neil
    Yancopoulos, George D.
    Shumel, Brad
    [J]. LANCET, 2017, 389 (10086) : 2287 - 2303
  • [10] Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
    Bolyen, Evan
    Rideout, Jai Ram
    Dillon, Matthew R.
    Bokulich, NicholasA.
    Abnet, Christian C.
    Al-Ghalith, Gabriel A.
    Alexander, Harriet
    Alm, Eric J.
    Arumugam, Manimozhiyan
    Asnicar, Francesco
    Bai, Yang
    Bisanz, Jordan E.
    Bittinger, Kyle
    Brejnrod, Asker
    Brislawn, Colin J.
    Brown, C. Titus
    Callahan, Benjamin J.
    Caraballo-Rodriguez, Andres Mauricio
    Chase, John
    Cope, Emily K.
    Da Silva, Ricardo
    Diener, Christian
    Dorrestein, Pieter C.
    Douglas, Gavin M.
    Durall, Daniel M.
    Duvallet, Claire
    Edwardson, Christian F.
    Ernst, Madeleine
    Estaki, Mehrbod
    Fouquier, Jennifer
    Gauglitz, Julia M.
    Gibbons, Sean M.
    Gibson, Deanna L.
    Gonzalez, Antonio
    Gorlick, Kestrel
    Guo, Jiarong
    Hillmann, Benjamin
    Holmes, Susan
    Holste, Hannes
    Huttenhower, Curtis
    Huttley, Gavin A.
    Janssen, Stefan
    Jarmusch, Alan K.
    Jiang, Lingjing
    Kaehler, Benjamin D.
    Bin Kang, Kyo
    Keefe, Christopher R.
    Keim, Paul
    Kelley, Scott T.
    Knights, Dan
    [J]. NATURE BIOTECHNOLOGY, 2019, 37 (08) : 852 - 857